Lab Analysis
Your labs tell a story over time.
MedConcil looks beyond individual high and low values to identify trends, patterns and relationships across your medical case.
ALT ref 7–45 U/L
Latest — 68 U/L
What the Council saw in this chart
ALT increased after a medication change
The rise began after the atorvastatin dose increased in February — a pattern worth reviewing with your physician.
HbA1c trend is improving
Down from 7.9% to 6.8% over 17 months. The current approach appears to be working.
LDL response looks consistent with therapy
A steady decline toward goal since the statin was started.
One additional test could clarify persistent fatigue
Ferritin sits near the low end of the reference range — a detail worth a conversation.
Beyond High and Low
How MedConcil reads your labs
Trends, not snapshots
A value moving in the wrong direction for a year means something different from a single out-of-range result. MedConcil reads the direction.
Relationships across markers
Labs are read next to each other — and next to medications, symptoms and diagnoses — because that's where the meaning lives.
Timing against changes
When a marker shifts after a medication change, that timing is part of the clinical picture. The Council looks for exactly these patterns.
Ready for a second clinical perspective?
Diagnosis. Treatment. Medications. Labs. DNA. History. Reviewed together.